戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 S, a decapping pyrophosphatase, and eIF4E, a translation initiation factor.
2 on has not been previously described for any translation initiation factor.
3  of 4E-BP was dependent on its partner eIF4E translation initiation factor.
4 ependent translation by binding to the eIF4E translation initiation factor.
5 t of a 5' cap and some/all of the associated translation initiation factors.
6 coordinated interaction of a large number of translation initiation factors.
7 tress granule protein G3BP1, and a subset of translation initiation factors.
8 l and cellular mRNAs to compete for limiting translation initiation factors.
9 fold, which was not observed before in other translation initiation factors.
10 that the W73V mutant could not interact with translation initiation factors.
11 oskeletal organization, and the abundance of translation initiation factors.
12   Remarkably, Sui(-) mutations in eukaryotic translation initiation factor 1 (eIF1), eIF1A, and eIF2b
13                 Extensive mutagenesis of the translation initiation factor-1 from Escherichia coli (E
14                                   Eukaryotic translation initiation factor 2 (eIF2) is a heterotrimer
15                               The eukaryotic translation initiation factor 2 (eIF2) is central to the
16  phosphorylation of the alpha subunit of the translation initiation factor 2 (eIF2alpha) in an AR-dep
17 d PERK specifically phosphorylate eukaryotic translation initiation factor 2 (eIF2alpha) on Ser51 to
18 nse in the liver, including alpha subunit of translation initiation factor 2 (eIF2alpha) phosphorylat
19 ntly increases phosphorylation of eukaryotic translation initiation factor 2 (eIF2alpha) resulting in
20                         Dephosphorylation of translation initiation factor 2 (eIF2alpha) terminates s
21 hosphorylate the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) to activate
22 orylation of the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha), is an impor
23 osphorylates the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2alpha), resulting i
24 osphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha), resulting i
25 ed dephosphorylation of the alpha subunit of translation initiation factor 2 (eIF2alpha).
26                                              Translation initiation factor 2 (IF2) promotes 30S initi
27 te (MMS), absence of the full-length form of Translation Initiation Factor 2 (IF2-1) or deficiency in
28 hat, translational control by the eukaryotic translation initiation factor 2 alpha (eIF2alpha) bidire
29 gulated inhibitor kinase (HRI), a eukaryotic translation initiation factor 2 alpha (eIF2alpha) kinase
30  kinase R (PKR) and its substrate eukaryotic translation initiation factor 2 alpha (eIF2alpha).
31 d activation (phosphorylation) of eukaryotic translation initiation factor 2 alpha kinase 3 (EIF2AK3,
32 hereas biallelic mutations in the eukaryotic translation initiation factor 2 alpha kinase 4 gene (EIF
33  result in phosphorylation of the eukaryotic translation initiation factor 2 subunit alpha (EIF2S1 or
34 mmaTE treatment increased phosphorylation of translation initiation factor 2, IkappaBalpha, and JNK,
35              Dephosphorylation of eukaryotic translation initiation factor 2a (eIF2a) restores protei
36                Phosphorylation of eukaryotic translation initiation factor 2alpha (eiF2alpha) and exp
37 lum stress and phosphorylation of eukaryotic translation initiation factor 2alpha (eIF2alpha) are ass
38                           Phosphorylation of translation initiation factor 2alpha (eIF2alpha) attenua
39            In eukaryotes, phosphorylation of translation initiation factor 2alpha (eIF2alpha) by the
40 tein levels in the heme-regulated eukaryotic translation initiation factor 2alpha (eIF2alpha) kinase
41 out (PERK-KO) or phosphodeficient eukaryotic translation initiation factor 2alpha (eIF2alpha) mouse e
42             As phosphorylation of eukaryotic translation initiation factor 2alpha (eIF2alpha) on Ser5
43 Ppp1r15b, a regulatory subunit of eukaryotic translation initiation factor 2alpha (eIF2alpha) phospha
44 rated stress response mediated by eukaryotic translation initiation factor 2alpha (eIF2alpha) phospho
45                               The eukaryotic translation initiation factor 2alpha (eIF2alpha) phospho
46 e the regulatory serine 51 of the eukaryotic translation initiation factor 2alpha (eIF2alpha) to inhi
47 se (UPR) associated with phosphorylation the translation initiation factor 2alpha (eIF2alpha), trigge
48 chment activates a canonical PERK-eukaryotic translation initiation factor 2alpha (eIF2alpha)-ATF4-CH
49 Ralpha and phosphorylation of the eukaryotic translation initiation factor 2alpha (eIF2alpha).
50 navirus encode a homologue of the eukaryotic translation initiation factor 2alpha (eIF2alpha).
51 edly increased phosphorylation of eukaryotic translation initiation factor 2alpha (p-eIF2alpha), an a
52 -dependent phosphorylation of the eukaryotic translation initiation factor 2alpha and enhanced transl
53 d that the PKR-like, ER-localized eukaryotic translation initiation factor 2alpha kinase branch of th
54                  This increase in eukaryotic translation initiation factor 2alpha phosphorylation was
55 h activating pancreatic ER kinase/eukaryotic translation initiation factor 2alpha signaling.
56 inding protein and phosphorylated eukaryotic translation initiation factor 2alpha unchanged.
57 protein kinase-like ER kinase and eukaryotic translation initiation factor 2alpha, and the induction
58 he latter of which phosphorylates eukaryotic translation initiation factor-2alpha (eIF2alpha).
59 slation initiation factor complex eukaryotic translation initiation factor 2B (eIF2B) and the very-lo
60 ng disease caused by mutations in eukaryotic translation initiation factor 2B (eIF2B).
61 ons in genes encoding subunits of eukaryotic translation initiation factor 2B (eIF2B).
62 nce 03 (retr03), an allele of the eukaryotic translation initiation factor 2B-beta (eIF2Bbeta).
63 nitiation pathway, the 13-subunit eukaryotic translation initiation factor 3 (eIF3) controls access o
64                                   Eukaryotic translation initiation factor 3 (eIF3) is a central play
65                                   Eukaryotic translation initiation factor 3 (eIF3) plays a central r
66                     We provide evidence that translation initiation factor 3 (IF3), an essential comp
67 nslation, a process that involved eukaryotic translation initiation factor 3 subunit b as a P311 bind
68  Two mutations were identified in eukaryotic translation initiation factor 3 subunit C (Eif3c).
69  addition, mTOR co-localised with Eukaryotic translation initiation factor 3 subunit F (eIF3F) at the
70                                   Eukaryotic translation initiation factor 3 subunit I (eIF3I) with t
71 t the protein translation factor, eukaryotic translation initiation factor 3, subunit a (eIF3a), bind
72 tease cleaves eIF3d, a subunit of eukaryotic translation initiation factor 3.
73                            eIF3a (eukaryotic translation initiation factor 3a), one of the core subun
74 assembly of the mRNA cap protein, eukaryotic translation initiation factor 4 (eIF4)E, with activators
75 exerted at initiation through the eukaryotic translation initiation factor 4 F (eIF4F).
76 dase E (CPE) by inhibition of the eukaryotic translation initiation factor 4 gamma 1 translation init
77 s process facilitates IFN-induced eukaryotic translation initiation factor 4A (eIF4A) activity and bi
78            DEAD-box RNA helicases eukaryotic translation initiation factor 4A (eIF4A) and Ded1 promot
79 d4(157-469), a deletion mutant that binds to translation initiation factor 4A (eIF4A), sufficiently i
80 ha2(I) mRNAs, by interacting with eukaryotic translation initiation factor 4A (eIF4A).
81 -, beta-, and gamma-subunits) and eukaryotic translation initiation factor 4A (three isoforms), altho
82                                   Eukaryotic translation initiation factor 4A is an essential compone
83     In cells depleted of CDK12 or eukaryotic translation initiation factor 4A3 (eIF4A3) from the EJC,
84 ibodies to EJC components Y14 and eukaryotic translation initiation factor 4aIII (eIF4AIII).
85 rary profiling, we identified the eukaryotic translation initiation factor 4B (eIF4B) as a MELK-inter
86     We confirmed that Asp(563) in eukaryotic translation initiation factor 4B (eIF4B) is a cleavage s
87                                   Eukaryotic translation initiation factor 4B (eIF4B) is a cofactor f
88 e found that the protein level of eukaryotic translation initiation factor 4B (eIF4B), an integral co
89  ORF45 induced phosphorylation of eukaryotic translation initiation factor 4B (eIF4B), increased its
90 phorylation of the S6K1-dependent eukaryotic translation initiation factor 4B.
91 tion factor 4E-binding protein 1/ eukaryotic translation initiation factor 4E (4EBP1/eIF4E) cascades.
92 loid leukemia (AML) by regulating eukaryotic translation initiation factor 4E (eIF4E) activation.
93 d to be based on mutations in the eukaryotic translation initiation factor 4E (eIF4E) and its isoform
94 ing serine/threonine kinase (MNK)-eukaryotic translation initiation factor 4E (eIF4E) axis is overexp
95                Here, we show that eukaryotic translation initiation factor 4E (eIF4E) binding protein
96                               The eukaryotic translation initiation factor 4E (eIF4E) binds to the 5'
97 ltaneous activation of mTORC1 and eukaryotic translation initiation factor 4E (eIF4E) by NS5A.
98  Here, we show that mice in which eukaryotic translation initiation factor 4E (eIF4E) cannot be phosp
99 ow that a functional reduction of eukaryotic translation initiation factor 4E (eIF4E) in Drosophila s
100 etically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in mice results
101 translation, and indicate that activation of translation initiation factor 4E (eIF4E) is involved in
102                                   Eukaryotic translation initiation factor 4E (eIF4E) is overexpresse
103                            Activation of the translation initiation factor 4E (eIF4E) promotes malign
104                                   Eukaryotic translation initiation factor 4E (eIF4E) promotes transl
105 kappaB alpha (IkappaB-alpha) S32, eukaryotic translation initiation factor 4E (eIF4E) S209, Smad2 S46
106        Importantly, either MYC or eukaryotic translation initiation factor 4E (eIF4E) was required to
107                    Association of eukaryotic translation initiation factor 4E (eIF4E) with eIF4E-bind
108 iation of the cap-binding protein eukaryotic translation initiation factor 4E (eIF4E) with eIF4G is a
109                 Here, we focus on eukaryotic translation initiation factor 4E (eIF4E), a prooncogenic
110 somal protein S6 kinase 1 (S6K1), eukaryotic translation initiation factor 4E (eIF4E), and autophagy,
111 Phosphorylation and activation of eukaryotic translation initiation factor 4E (eIF4E), eIF4E-binding
112 lated or minimally phosphorylated form binds translation initiation factor 4E (eIF4E), preventing bin
113 o Mnk1 lead to phosphorylation of eukaryotic translation initiation factor 4E (eIF4E), which has been
114 imiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), which is negat
115 e analogues were bound tightly to eukaryotic translation initiation factor 4E (eIF4E), with CCl2-subs
116 o target a specific oncogene, the eukaryotic translation initiation factor 4E (eIF4E), with its inhib
117 ed expression of the translational repressor translation initiation factor 4E (eIF4E)-binding protein
118 d translation of MTFP1, which is mediated by translation initiation factor 4E (eIF4E)-binding protein
119  inhibited phosphorylation of the eukaryotic translation initiation factor 4E (eIF4E)-binding protein
120 t Eap1p, which is a member of the eukaryotic translation initiation factor 4E (eIF4E)-binding protein
121 mice, we investigated the role of eukaryotic translation initiation factor 4E (eIF4E)-eIF4G interacti
122 ignaling are required to activate eukaryotic translation initiation factor 4E (eIF4E)-initiated cap-d
123 ain, which displays similarity to eukaryotic translation initiation factor 4E (eIF4E).
124 on is dependent on mTORC1 and the eukaryotic translation initiation factor 4E (eIF4E).
125    eIF4E1b, closely related to the canonical translation initiation factor 4E (eIF4E1a), cap-binding
126 ockade of its downstream effector eukaryotic translation initiation factor 4E activity equally reduce
127 achinery, decreases expression of eukaryotic translation initiation factor 4E and cyclin D1, and indu
128 tion, 4E binding protein 1 (4E-BP1) binds to translation initiation factor 4E and inhibits cap-depend
129 ate the importance of the p38-MNK-eukaryotic translation initiation factor 4E axis in TNF production
130 otein S6, S6 kinase 1 (S6K1), and eukaryotic translation initiation factor 4E binding protein 1 (4E-B
131 TOR)-dependent phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 (4EBP
132 d even under conditions of inhibition of the translation initiation factor 4E function mediated by LY
133 educe the level of phosphorylated eukaryotic translation initiation factor 4E in the tumor tissues.
134 lates the alternative splicing of eukaryotic translation initiation factor 4E nuclear import factor 1
135 ammalian target of rapamycin, and eukaryotic translation initiation factor 4E phosphorylation seen in
136        A trend for an increase of eukaryotic translation initiation factor 4E phosphorylation was obs
137 r 1 (Eif4enif1), which encodes an eukaryotic translation initiation factor 4E transporter (4E-T) prot
138 rget of rapamycin, phosphorylated eukaryotic translation initiation factor 4E, phosphorylated 4E-bind
139 APK-interacting kinase (MNK), and eukaryotic translation initiation factor 4E, which is a critical re
140 A-RNA interaction and an adjacent eukaryotic translation initiation factor 4E-binding 3'CITE.
141 p T-shaped structure (kl-TSS) and eukaryotic translation initiation factor 4E-binding Panicum mosaic
142        mTORC1 activation inhibits eukaryotic translation initiation factor 4E-binding protein (4E-BP)
143 malian target of rapamycin (mTOR)/eukaryotic translation initiation factor 4E-binding protein (4E-BP)
144 OR) signaling pathway to preserve eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
145 ribosomal protein S6 kinase 1 (S6K1) and the translation initiation factor 4E-binding protein 1 (4E-B
146  serine 345 (S345), Chk 2 S33/35, eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
147 rget of rapamycin (mTOR)-directed eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
148  revealed hyperphosphorylation of eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
149  first, it preferentially targets eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
150                                   Eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
151 ibosomal protein S6 kinase 1, and eukaryotic translation initiation factor 4E-binding protein 1 durin
152 K/ribosomal protein S6 (RPS6) and eukaryotic translation initiation factor 4E-binding protein 1/ euka
153       Using mice with deletion of eukaryotic translation initiation factor 4E-binding protein 2 (4E-B
154 l-cycle regulators via the mTORC1/eukaryotic translation initiation factor 4E-binding protein pathway
155 the translation repressor, 4E-BP (eukaryotic translation initiation factor 4E-binding protein).
156 lls through the activation of the eukaryotic translation initiation factor 4E/MAPK-interacting kinase
157                    Disrupting the eukaryotic translation initiation factor 4F (eIF4F) complex offers
158                                   Eukaryotic translation initiation factor 4F (eIF4F), comprising the
159  (eIF4G), the scaffold subunit of eukaryotic translation initiation factor 4F (eIF4F), preferentially
160 are required for formation of the eukaryotic translation initiation factor 4F complex (eIF4F) and ini
161                         MNK binds eukaryotic translation initiation factor 4G (eIF4G) and phosphoryla
162  Ser-rich segment (RS1 domain) of eukaryotic translation initiation factor 4G (eIF4G) and the Lys-ric
163             Remarkably, depleting eukaryotic translation initiation factor 4G (eIF4G), the scaffold s
164 on initiation by interaction with eukaryotic translation initiation factor 4G (eIF4G), we investigate
165 nding partners containing a middle domain of translation initiation factor 4G (MIF4G) are emerging as
166 to bind the poly(A) tail of mRNA, as well as translation initiation factor 4G and eukaryotic release
167  protein synthesis and levels of eukaryotic (translation) initiation factor 4G1 (eIF4G1).
168                                   Eukaryotic translation initiation factor 4h (Eif4h) encodes a prote
169 ionine decarboxylase 1 (AMD1) and eukaryotic translation initiation factor 5A (eIF5A), two genes asso
170 for deoxyhypusine modification of eukaryotic translation initiation factor 5A (eIF5A).
171 rently known hypusinated protein, eukaryotic translation initiation factor 5A.
172        Two of these proteins, are eukaryotic translation initiation factor 5A1 (eIF5A1) that is invol
173 ta reveal a transient increase of eukaryotic translation initiation factor 5B (eIF5B), the eukaryotic
174 anslation initiation via an interaction with translation initiation factor 5B (eIF5B).
175 ng is controlled by the G-protein eukaryotic translation initiation factor 5B (eIF5B).
176 nduced protein kinase R (PKR) and eukaryotic translation initiation factor alpha (eIF2alpha) phosphor
177 doplasmic reticulum kinase (PERK)-eukaryotic translation initiation factor alpha (eIF2alpha)-CEBP hom
178 omitant with elevated phosphorylation of the translation initiation factor alpha subunit of eukaryoti
179  acids led to significant down-regulation in translation initiation factors, amino acid metabolism, a
180 onucleoprotein (mRNP) aggregates composed of translation initiation factors and mRNAs that appear whe
181 g mRNA-binding proteins, ribosomal proteins, translation initiation factors and translation elongatio
182 election by 5' upstream open reading frames, translation initiation factors, and primary and secondar
183 ing proteins (PABPs) link mRNA 3' termini to translation initiation factors, but they also play key r
184 f eukaryotic initiation factor 2 (eIF2alpha) translation initiation factor by a variety of cellular s
185 udies suggest that the reduced activity of a translation initiation factor called eIF2alpha might be
186 tion between the eIF4E/eIF4G subunits of the translation initiation factor complex eIF4F is a hallmar
187 assays, we show the Saccharomyces cerevisiae translation initiation factor complex eukaryotic transla
188  to identify the components of the norovirus translation initiation factor complex.
189  demonstrates that viruses can increase host translation initiation factor concentration to foster th
190                              Deregulation of translation initiation factors contributes to many patho
191 ed in the MIF4G domain of CBP80/20-dependent translation initiation factor (CTIF).
192       Yet, no signals specifically targeting translation initiation factors during mitosis have been
193  factors such as ribosomal protein RPS-1 and translation initiation factor EIF-3.J to reduce infectio
194 SG formation is triggered by both eukaryotic translation initiation factor (eIF) 2alpha phosphorylati
195 thways convergently signal to the eukaryotic translation initiation factor (eIF) 4F complex to regula
196                               The eukaryotic translation initiation factor (eIF) 4G is a scaffold pro
197                               The eukaryotic translation initiation factor (eIF) 4G is required durin
198 or remained putative for decades: eukaryotic translation initiation factor (eIF) 5A.
199                          Here we report that translation initiation factor eIF1A directly interacts w
200  phosphorylation of the alpha subunit of the translation initiation factor eIF2 (eIF2alpha) can promo
201 hosphorylates and in end-effect inhibits the translation initiation factor eIF2 (eukaryotic initiatio
202 ase (OAS), which respectively inactivate the translation initiation factor eIF2 and stimulate RNA cle
203                                  The general translation initiation factor eIF2 is a major translatio
204 eIF2B GEF activity toward its substrate, the translation initiation factor eIF2, in vitro.
205 orylates the alpha subunit of the eukaryotic translation initiation factor eIF2, leading to global do
206 orylation of the alpha-subunit of eukaryotic translation initiation factor, eIF2.
207 nslational control by phosphorylation of the translation initiation factor eIF2alpha (p-eIF2alpha) ac
208  gene product, phosphorylates the eukaryotic translation initiation factor eIF2alpha and causes trans
209 riggered by increased phosphorylation of the translation initiation factor eIF2alpha and the protein
210 induces Perk-mediated phosphorylation of the translation initiation factor eif2alpha causing selectiv
211   PKR activation leads to phosphorylation of translation initiation factor eIF2alpha inhibition of pr
212 host response to virus infection mediated by translation initiation factor eIF2alpha phosphorylation.
213 study, we found that reduced activity of the translation initiation factor eIF2alpha underlies the hy
214                          PKR inactivates the translation initiation factor eIF2alpha via phosphorylat
215 evels, an extensive dephosphorylation of the translation initiation factor eIF2alpha was observed dur
216 ted by the stress-induced phosphorylation of translation initiation factor eIF2alpha, and this inhibi
217 tivation by PACT leads to phosphorylation of translation initiation factor eIF2alpha, inhibition of p
218 s (MRV) infection induces phosphorylation of translation initiation factor eIF2alpha, which promotes
219 lar stress responses, by phosphorylating the translation initiation factor eIF2alpha.
220 that are mediated via phosphorylation of the translation initiation factor eIF2alpha.
221 otein translation via phosphorylation of the translation initiation factor eIF2alpha.
222 atase activity, dephosphorylating eukaryotic translation initiation factor (eIF2alpha), and derepress
223 s MITF via ATF4 in response to inhibition of translation initiation factor eIF2B.
224 , we show that the mRNAs encoding eukaryotic translation initiation factors eIF2B2 and eIF4G2 are pre
225 ng the local protein synthesis of eukaryotic translation initiation factors eIF2B2 and eIF4G2 in the
226 nection between the structure of the central translation initiation factor eIF3 and recognition of th
227                      By interacting with the translation initiation factor eIF3, Cpeb4 represses the
228 teracts directly with the pivotal eukaryotic translation initiation factor eIF3.
229  the gene encoding eIF3e, the p48 subunit of translation initiation factor eIF3.
230 oaded onto capped mRNAs via the multisubunit translation initiation factors eIF3 and eIF4F.
231  motif (SBM) in two additional proteins: the translation initiation factor eIF3g and the mRNA-export
232                  Moreover, overexpression of translation initiation factor eIF4A, a helicase, enhance
233 promotes deamidation of glutamine-339 of the translation initiation factor eIF4A, abolishing its heli
234  was associated with increased expression of translation initiation factors eIF4A and eIF4GI, and red
235 wding on structure and function of the human translation initiation factors eIF4A, a two-domain DEAD-
236 e regulates the expression of the eukaryotic translation initiation factor EIF4A1, the tumor suppress
237                                The principal translation initiation factor eIF4AI displays helicase a
238                                   Eukaryotic translation initiation factor eIF4AI, the founding membe
239 d activity of mTORC1 and its downstream mRNA translation initiation factors eIF4B and 4EBP1, as well
240  through the phosphorylation of a eukaryotic translation initiation factor, eIF4B.
241 UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activ
242  of mTOR despite hypoxia involves release of translation initiation factor eIF4E from its repressor p
243          Overexpression of the rate-limiting translation initiation factor eIF4E induced Rae1 and ULB
244                                          The translation initiation factor eIF4E is an oncogene that
245                                              Translation initiation factor eIF4E mediates normal cell
246            The interaction of the eukaryotic translation initiation factor eIF4E with the initiation
247                                   Eukaryotic translation initiation factor eIF4E, an essential compon
248                  We show that the eukaryotic translation initiation factor eIF4E, an oncoprotein, dri
249 in part, by elevated levels of the activated translation initiation factor eIF4E, overexpression of w
250 d the calcineurin regulator Rcn2, the 4E-BP (translation initiation factor eIF4E-binding protein) tra
251 ltiple ribosome biogenesis genes and the key translation initiation factor eIF4E.
252 s via a direct interaction with the cellular translation initiation factor eIF4E.
253 s its association with and inhibition of the translation initiation factor eIF4E.
254 A translation initiation by sequestering the translation initiation factor eIF4E.
255                               The eukaryotic translation-initiation factor eIF4E is a rate-limiting f
256 utcomes and include targeting the eukaryotic translation initiation factor (eIF4E) with its inhibitor
257 tance to asTORi by downregulating eukaryotic translation initiation factor (eIF4E)-binding proteins (
258 phosphate mRNA cap analogues with eukaryotic translation initiation factor (eIF4E).
259 e based on mutations in the plant eukaryotic translation initiation factors, eIF4E and eIF4G or their
260                                    The eIF4E translation initiation factors, eIF4E1, eIF4E2, and eIF4
261                                              Translation initiation factor eIF4F (eukaryotic initiati
262 clude the ability to bind a component of the translation initiation factor eIF4F complex and to engag
263 It relies on its ability to compete with the translation initiation factor eIF4F to specifically reco
264  translation by binding the eIF4G subunit of translation initiation factor eIF4F with high affinity.
265 he ability of infected cells to assemble the translation initiation factor eIF4F, promoting viral pro
266 ciated with the 4F subunit of the eukaryotic translation initiation factor (eIF4F) complex in infecte
267 ated in splicing, interacts with the general translation initiation factor eIF4G and promotes transla
268 on factor 4A (eIF4A) activity and binding to translation initiation factor eIF4G to promote mRNA tran
269 gnition, the poly(A) binding protein and the translation initiation factor eIF4G.
270 f from the viral polyprotein and cleaves the translation initiation factor eIF4G.
271 untranslated region that interacts with host translation initiation factor eIF4G.
272  mRNA translation mediated by high levels of translation initiation factor eIF4G1 (eukaryotic initiat
273 trate that calpain-mediated degradation of a translation initiation factor, eIF4G1, is a cause of bot
274                                Vhs binds the translation initiation factors eIF4H, eIF4AI, and eIF4AI
275 carcinoma (PDAC), mutant KRAS stimulates the translation initiation factor eIF5A and upregulates the
276 ch to investigate the role of the eukaryotic translation initiation factor eIF5A in human cervical ca
277                                   Eukaryotic translation initiation factor eIF5A promotes protein syn
278 DOHH) catalyzes the activation of eukaryotic translation initiation factor (eIF5A), a protein essenti
279        The process is mediated by eukaryotic translation initiation factors (eIFs) in conjunction wit
280 nt with a decrease in phosphorylation of the translation initiation factor eukaryotic initiation fact
281  Global translation is regulated through the translation initiation factor eukaryotic initiation fact
282 osphorylation-mediated inactivation of a key translation initiation factor, eukaryotic initiation fac
283 uded ribosomal proteins, nucleolar proteins, translation initiation factors, helicases, and hnRNPs.
284 ely to the poorly characterized domain II of translation initiation factor IF2 and prevented the bind
285                                    Bacterial translation initiation factor IF2 promotes ribosomal sub
286  element (ARE)-binding protein that recruits translation initiation factors, molecular chaperones, an
287 mes postinfection and contains TIA but lacks translation initiation factors, mRNA binding proteins, a
288                    By commandeering cellular translation initiation factors, or destroying those disp
289 ity, induced oxidative stress, or stimulated translation initiation factor phosphorylation significan
290 l-restricted intracellular antigen 1 (TIA1), translation initiation factors, RNA binding proteins, an
291  protein expression in adipose tissue of the translation initiation factor serine-kinase-6-1, which i
292 SPONSE TO DEHYDRATION14, AUXIN RESISTANT1, a translation initiation factor SUI1 family protein, and t
293             These results identify Ded1 as a translation initiation factor that assembles and remodel
294 A1 and its highly related isoform eIF5A2 are translation initiation factors that have been implicated
295  which serves as a scaffold to recruit other translation initiation factors that ultimately assemble
296  arrest mediated by the phosphorylation of a translation initiation factor, the alpha subunit of euka
297 tion either by sterically blocking access of translation initiation factors to the 5'-cap or by activ
298 he ASOs appear to improve the recruitment of translation initiation factors to the target mRNA.
299 es the eukaryotic initiation factor 2 (eIF2) translation initiation factor upon binding to viral doub
300 s that relies on the interaction of cellular translation initiation factors with the virus genome-enc
301  mechanism that relies on the interaction of translation initiation factors with the virus-encoded VP

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top